Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran

Purpose: To evaluate colistin use according to global standard drug consumption in intensive care units of a referral hospital in Shiraz, Iran Methods: A prospective, interventional study was performed during an 11 month period on 100 patients admitted to ICUs of a teaching hospital being treated wi...

Full description

Bibliographic Details
Main Authors: Afsaneh Vazin, Iman Karimzadeh, Atiyeh Zand, Nazafarin Hatami-Mazinani, Dena Firouzabadi
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2017-09-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:http://journals.tbzmed.ac.ir/APB/Manuscript/APB-7-391.pdf
_version_ 1811251582557224960
author Afsaneh Vazin
Iman Karimzadeh
Atiyeh Zand
Nazafarin Hatami-Mazinani
Dena Firouzabadi
author_facet Afsaneh Vazin
Iman Karimzadeh
Atiyeh Zand
Nazafarin Hatami-Mazinani
Dena Firouzabadi
author_sort Afsaneh Vazin
collection DOAJ
description Purpose: To evaluate colistin use according to global standard drug consumption in intensive care units of a referral hospital in Shiraz, Iran Methods: A prospective, interventional study was performed during an 11 month period on 100 patients admitted to ICUs of a teaching hospital being treated with colistin for at least 3 subsequent doses. Required demographic, clinical, and paraclinical data were gathered by a pharmacist. Fifteen indexes were considered to evaluate colistin use. A clinical pharmacist reviewed indication and dose of colistin at the time of prescribing this agent. Results: In our study population, pneumonia (69%) was the main indication of colistin. In 87% of patients, colistin administration was based on microbiological laboratory evidence. Continuation of therapy was inappropriate in 5% of cases. By the intervention of the clinical pharmacist, colistin was discontinued in all patients in whom empirical therapy was continued incorrectly. None of the patients received loading dose of colistin. The maintenance dose, dose interval, and duration of treatment of colistin were appropriate in 76%, 71%, and 100% of patients, respectively. For none of the patients, the pharmacokinetic dosing method was used. In all patients, serum creatinine and WBC count were evaluated on daily basis. The sum indexes of colistin use were relevant to standard guidelines in 67.33% of the cases.Conclusion: The results of this study highlight the necessity of the pharmaceutical care team participation in all stages of treatment with antibiotics. After pharmacist interventions, some criteria of colistin utilization were corrected and brought closer to standard values.
first_indexed 2024-04-12T16:22:35Z
format Article
id doaj.art-1623eb62fcdc4af781e7f28ef7360e60
institution Directory Open Access Journal
issn 2228-5881
2251-7308
language English
last_indexed 2024-04-12T16:22:35Z
publishDate 2017-09-01
publisher Tabriz University of Medical Sciences
record_format Article
series Advanced Pharmaceutical Bulletin
spelling doaj.art-1623eb62fcdc4af781e7f28ef7360e602022-12-22T03:25:31ZengTabriz University of Medical SciencesAdvanced Pharmaceutical Bulletin2228-58812251-73082017-09-017339139710.15171/apb.2017.047APB_16083_20170118181208Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of IranAfsaneh Vazin0Iman Karimzadeh1Atiyeh Zand2Nazafarin Hatami-Mazinani3Dena Firouzabadi4Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.Purpose: To evaluate colistin use according to global standard drug consumption in intensive care units of a referral hospital in Shiraz, Iran Methods: A prospective, interventional study was performed during an 11 month period on 100 patients admitted to ICUs of a teaching hospital being treated with colistin for at least 3 subsequent doses. Required demographic, clinical, and paraclinical data were gathered by a pharmacist. Fifteen indexes were considered to evaluate colistin use. A clinical pharmacist reviewed indication and dose of colistin at the time of prescribing this agent. Results: In our study population, pneumonia (69%) was the main indication of colistin. In 87% of patients, colistin administration was based on microbiological laboratory evidence. Continuation of therapy was inappropriate in 5% of cases. By the intervention of the clinical pharmacist, colistin was discontinued in all patients in whom empirical therapy was continued incorrectly. None of the patients received loading dose of colistin. The maintenance dose, dose interval, and duration of treatment of colistin were appropriate in 76%, 71%, and 100% of patients, respectively. For none of the patients, the pharmacokinetic dosing method was used. In all patients, serum creatinine and WBC count were evaluated on daily basis. The sum indexes of colistin use were relevant to standard guidelines in 67.33% of the cases.Conclusion: The results of this study highlight the necessity of the pharmaceutical care team participation in all stages of treatment with antibiotics. After pharmacist interventions, some criteria of colistin utilization were corrected and brought closer to standard values.http://journals.tbzmed.ac.ir/APB/Manuscript/APB-7-391.pdfColistin guidelineAdherenceClinical PharmacistIntensive care unit
spellingShingle Afsaneh Vazin
Iman Karimzadeh
Atiyeh Zand
Nazafarin Hatami-Mazinani
Dena Firouzabadi
Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
Advanced Pharmaceutical Bulletin
Colistin guideline
Adherence
Clinical Pharmacist
Intensive care unit
title Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
title_full Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
title_fullStr Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
title_full_unstemmed Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
title_short Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
title_sort evaluating adherence of health care team to standard guideline of colistin use at intensive care units of a referral hospital in shiraz southwest of iran
topic Colistin guideline
Adherence
Clinical Pharmacist
Intensive care unit
url http://journals.tbzmed.ac.ir/APB/Manuscript/APB-7-391.pdf
work_keys_str_mv AT afsanehvazin evaluatingadherenceofhealthcareteamtostandardguidelineofcolistinuseatintensivecareunitsofareferralhospitalinshirazsouthwestofiran
AT imankarimzadeh evaluatingadherenceofhealthcareteamtostandardguidelineofcolistinuseatintensivecareunitsofareferralhospitalinshirazsouthwestofiran
AT atiyehzand evaluatingadherenceofhealthcareteamtostandardguidelineofcolistinuseatintensivecareunitsofareferralhospitalinshirazsouthwestofiran
AT nazafarinhatamimazinani evaluatingadherenceofhealthcareteamtostandardguidelineofcolistinuseatintensivecareunitsofareferralhospitalinshirazsouthwestofiran
AT denafirouzabadi evaluatingadherenceofhealthcareteamtostandardguidelineofcolistinuseatintensivecareunitsofareferralhospitalinshirazsouthwestofiran